March 2026

Recognition at the 51st International Exhibition of Inventions of Geneva

HKU’s Innovation Excellence Garners 46 Awards
51st International Exhibition of Inventions of Geneva

What does creativity look like? Imagine being surrounded by over 1,000 of the newest, rigorously researched and eye-openingly creative inventions from 35 countries and regions around the world. This is what you would have encountered at the 51st International Exhibition of Inventions of Geneva, one of the world’s most prestigious events dedicated exclusively to inventions and innovations.

Held this year from March 11 to 15 in Geneva, Switzerland, the event brought together inventors, research institutions, and industry leaders from around the world, and provided an important platform for showcasing technological breakthroughs and fostering international collaboration.

HKU presented 45 research inventions from various faculties, schools and HKU’s InnoHK research laboratories at this year’s exhibition, addressing critical challenges across various fields, ranging from health and biomedicine, to smart engineering, artificial intelligence (AI), energy and sustainability technologies, advanced manufacturing and more. This diverse portfolio highlights the University’s strategic focus and commitment to driving cross-disciplinary research and innovation, strengthening its role as a leader in research and innovation, while also translating academic discoveries into impactful global solutions.

And this is where HKU has been able to continue building its global impact for outstanding research and innovation excellence. After an international jury of specialists evaluated the entire field of inventions, HKU received 46 awards – 1 esteemed Special Grand Prize, 9 Gold Medals with Congratulations of the Jury, 13 Gold, 19 Silver and 4 Bronze medals.

Our warmest congratulations to all the winning teams!

The project awarded the Special Grand Prize – Prize of the Chinese Delegation and Gold Medal with Congratulations of the Jury

Nose-to-brain nanopowder nasal spray for rapid ischemic stroke rescue

The project is a pioneering portable, accessible and affordable first-aid intervention for ischemic stroke. Through incorporating advanced nanotechnology and inhalation science, this innovative invention reformulates neurotherapeutics into nanopowder for nose-to-brain delivery. This means that with just one spray, stroke patients can have their brain and body protected immediately, even before reaching the hospital. This invention has the game-changing potential to empower quality of life and lower healthcare burden worldwide. The project is led by Professor Chow Shing-fung from the Department of Pharmacology and Pharmacy and the Advanced Biomedical Instrumentation Centre.

Projects awarded the Gold Medal with Congratulations of the Jury

A novel immunisation method and powder: Gaining immunity against the three major respiratory viruses through home-based toothbrushing

This invention introduces a home-based immunisation method integrated into weekly toothbrushing using a specific 3-in-1 powder that induces mucosal protection against COVID-19, influenza, and RSV after five once-weekly brushing applications. The project is led by Professor Raven Kok Kin-hang from the Department of Microbiology, School of Clinical Medicine.

A portable device for non-invasive and rapid cancer detection using AI-powered optical sensing

This invention is a portable device for rapid, non-invasive cancer risk assessment. It detects DNA damage levels in saliva using innovative luminescent metal compounds and a miniature spectral sensor. Its detection can be finished within 10 minutes anywhere with the help of mobile phone app, requiring no professional medical skills. It provides a routine and convenient approach to evaluate cancer risk. The project is led by Professor Che Chi-ming and Dr Wei Liu from the Laboratory for Synthetic Chemistry and Chemical Biology Limited.

AA4Sci: AI-powered platform for energy materials innovation

The project is an AI-powered platform revolutionising energy material innovation. It combines a smart literature reader with Graph RAG technology to parse and structure vast scientific papers. By integrating specialised NER and Knowledge Graphs, the system transforms unstructured text into actionable insights. Intelligent Large Language Model (LLM) Agents perform multi-hop reasoning to discover new materials and generate optimal synthesis paths. This end-to-end solution accelerates R&D cycles, automating the journey from reading literature to scientific discovery. The project is led by Professor Guanhua Chen from the Department of Chemistry and Dr Jie Liu from the Hong Kong Quantum AI Lab.

eCheckGo: A large defect model-driven AI system for ultra-fast and scalable building inspection in high-density cities

This invention introduces eCheckGo, an AI system driven by a large defect model (LdM) for mass building inspection. It takes up two long-standing challenges in high-density contexts: the time-consuming nature of manual inspections and the difficulty of case-specific AI training. At the core is the proprietary LdM – a multi-modal large language model tailored for building inspection. Powered by LdM’s strong generalisability, eCheckGo delivers ultra-fast assessments and exceptional adaptability. The project is led by Professor Junjie Chen, Professor Wilson Lu, Dr Junping Zhong and Mr Yonglin Fu from the Department of Real Estate and Construction.

Rapid finger-prick blood test for diagnosis, early prediction of relapse subtypes and treatment monitoring of Epstein-Barr virus-associated nasopharyngeal carcinoma (NPC)

This project focusses on developing a rapid, non-invasive finger-prick blood test based on a three-marker panel, enabling diagnosis, treatment monitoring and early relapse risk prediction, including potential relapse subtypes, in EBV-associated nasopharyngeal carcinoma. This method offers pinpoint accuracy outperforming the conventional EBV DNA blood test. Together with its user-friendly design and high affordability, it allows patients to perform tests comfortably at home while keeping track of their disease progression along the course of treatment enabling timely interventions to improve outcome. The project is led by Professor Victor Lee Ho-fun, Dr Eymon Wu Ka-chun and Mr Syrus Lai Pa-hei from the Department of Clinical Oncology, School of Clinical Medicine.

Rapid point-of-care molecular detection of evolving mosquito-borne viruses

This invention provides an isothermal nucleic acid-based method and reagent kits for POCT of mosquito-borne viruses within 15 minutes, with serotype-level resolution. It overcomes logistical constraints of current approaches, enabling rapid, accurate, and sensitive detection while remaining robust to diverse virus variants. This invention has been validated by in-silico tests and real-world samples, offering an effective solution for mosquito-borne virus detection in different environments including hospitals, clinics, customs, and community. The project is led by Professor Tommy Lam Tsan-yuk from the School of Public Health, and Dr Ji Wang and Dr Yunshi Liao from the Centre for Immunology & Infection.

Rhytma: A rapid and quantitative biochemical hormone monitor for mobile and smart-devices

The project introduces a groundbreaking, non-invasive biosensor that continuously delivers laboratory-grade hormone analytics to smart devices, empowering women to monitor health through motherhood and menopause. Protected by five IP filings, integrated AI transforms real-time results into personalised, actionable guidance – offering precision and convenience unmatched by current home tests. The project is led by Professor Julian Tanner from HKUMed and the Advanced Biomedical Instrumentation Centre.

Universal droplet robotics for digital diagnostics

A contactless droplet robotic platform is being developed to automate immune cell function testing directly from patients’ blood. Using electrostatic droplet handling, it standardises fragile living cell stimulation, incubation, and biomarker detection in a closed workflow. The proposed system is intended to support precise immunosuppressant dosage for post-transplant patients by enabling repeatable, clinically actionable immune-function readouts beyond current therapeutic drug monitoring. The project is led by Professor Shum Ho-cheung, Dr Ruotong Zhang and Dr Zheqi Chen from the Advanced Biomedical Instrumentation Centre.

YOU MAY ALSO LIKE

Initiated and hosted by HKU’s Institute for Climate and Carbon Neutrality, Hong Kong Climate Week 2026 aimed to harness Hong Kong’s unique strengths as an international financial centre and a global connectivity hub to accelerate a just, inclusive and resilient net-zero transition.
Professor Cecilia Chan Ka-yuk and partners introduce SuperTA, an innovative AI-driven education tool that is designed to enhance teaching practices in the GenAI era and is available to educators at all levels.
HKU’s ultra-thin diamond fabrication technology – enabling large-scale, high-quality production of diamond membranes with implications for next-generation electronic and optical devices – has been selected as one of China’s Top 10 Scientific Advances of 2025.
HKU WeChat